Pfizer: The Long Suffering Is Finally Over (Rating Upgrade)
PfizerPfizer(US:PFE) Seeking Alpha·2025-10-02 13:00

Core Insights - JR Research is recognized as a top analyst in technology, software, and internet sectors, focusing on growth and GARP strategies [1] - The investment approach emphasizes identifying attractive risk/reward opportunities with strong price action to generate alpha above the S&P 500 [1][2] - The investment group Ultimate Growth Investing specializes in high-potential opportunities across various sectors, targeting stocks with strong growth potential and significant recovery possibilities [3] Investment Strategy - The focus is on growth investing opportunities that offer the most attractive risk/reward upside potential, combining price action analysis with fundamental investing [2] - The strategy avoids overhyped and overvalued stocks while capitalizing on beaten-down stocks with significant upside recovery potential [2] Group Specialization - Ultimate Growth Investing targets ideas with strong growth potential and contrarian plays, with an investment horizon of 18 to 24 months for the thesis to materialize [3] - The group is designed for investors looking to capitalize on growth stocks with robust fundamentals, buying momentum, and turnaround plays at attractive valuations [3]